Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 168
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Do fungi exposed to toxic waste produce novel antimicrobial agents?

We've discovered a few new mushrooms thriving in this harsh environment of land-disposed sewage sludge in...

A Prescription for Health and Fitness Based on Your Genes

Exercise has many health benefits. Yet, most people stop their exercise programs after they start them...

Mathematical model to reduce maternal and infant mortality in Southeast Asia

Maternal and child mortality in Southeast Asian countries is still very high, especially in poor and rural...

Backer Badge Funded